Tier 2

Tier 2 publications

	File	Modified
Labels No labels Preview View	PDF File Impact of Target‐Mediated Elimination on the Dose and Regimen of Evolocumab a Human Monoclonal Antibody Against Proprotein Convertase SubtilisinKexin Type 9 PCSK9.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Motavizumab-YTE Robbie et al.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Ortega_et_al-2014-Clinical_Pharmacology_in_Drug_Development Mepo SC parameters.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Pharmacokinetic pharmacodynamic profile of reslizumab in asthma Matera 2018.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Pharmacokinetics and Safety of Elotuzumab with Myeloma and various levels of renal impairment Berdeja et al 2016.pdf	Dec 19, 2018 by Dave Fairman (Deactivated)
Labels No labels Preview View	PDF File Zhuang_et_al-2017-Clinical_Pharmacology_in_Drug_Development Sirukimab IV SC absolute F design..pdf	Dec 19, 2018 by Dave Fairman (Deactivated)

Download All